Our online eligibility checklist helps you see which type of
finance might be right for your business.
The North West Fund for Biomedical provides a flexible
equity package for growth oriented businesses operating within the
This includes companies involved in pharmaceuticals (research,
development and manufacture of drugs and biopharmaceuticals);
biotechnology; diagnostics; clinical research organisations;
contract manufacturing organisations; analytical services and
sciences; and healthcare technologies and medical devices.
The North West Fund for Biomedical provides finance from £50,000
to £1.5m to businesses seeking finance to support a broad
range of needs from start-up and early stage development through to
expansion plans for trading businesses. In return, the Fund Manager
will require an equity share in the business. Capital structures
can include a combination of equity, quasi-equity or mezzanine
capital and loan support as best suits the needs of the
SPARK Impact manages
the North West Fund for Biomedical. For further information
about this fund contact Spark Impact by email or telephone
Louise Clancy on 020 7851 7732.